Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
8.19
-0.21 (-2.50%)
At close: May 11, 2026, 4:00 PM EDT
8.19
0.00 (0.00%)
After-hours: May 11, 2026, 7:38 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $850.05 million as of May 11, 2026. Its market cap has increased by 214.31% in one year.
Market Cap
850.05M
Enterprise Value
752.30M
1-Year Change
214.31%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $850.05M, an increase of 113.72%. That is a compound annual growth rate of 18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 850.05M | 145.61% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 891.71M |
| Janux Therapeutics | 867.81M |
| Arbutus Biopharma | 864.57M |
| Alto Neuroscience | 859.84M |
| ARS Pharmaceuticals | 853.99M |
| Theravance Biopharma | 851.66M |
| Kura Oncology | 844.13M |
| CytomX Therapeutics | 840.30M |